title: Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians.
abstract: BACKGROUND
  Global coronary heart disease (CHD) risk assessment is recommended to guide primary preventive pharmacotherapy. However, little is known about physicians' understanding and use of global CHD risk assessment. Our objective was to examine US physicians' awareness, use, and attitudes regarding global CHD risk assessment in clinical practice, and how these vary by provider specialty.
  
  
  METHODS
  Using a web-based survey of US family physicians, general internists, and cardiologists, we examined awareness of tools available to calculate CHD risk, method and use of CHD risk assessment, attitudes towards CHD risk assessment, and frequency of using CHD risk assessment to guide recommendations of aspirin, lipid-lowering and blood pressure (BP) lowering therapies for primary prevention. Characteristics of physicians indicating they use CHD risk assessments were compared in unadjusted and adjusted analyses.
  
  
  RESULTS
  A total of 952 physicians completed the questionnaire, with 92% reporting awareness of tools available to calculate CHD global risk. Among those aware of such tools, over 80% agreed that CHD risk calculation is useful, improves patient care, and leads to better decisions about recommending preventive therapies. However, only 41% use CHD risk assessment in practice. The most commonly reported barrier to CHD risk assessment is that it is too time consuming. Among respondents who calculate global CHD risk, 69% indicated they use it to guide lipid lowering therapy recommendations; 54% use it to guide aspirin therapy recommendations; and 48% use it to guide BP lowering therapy. Only 40% of respondents who use global CHD risk routinely tell patients their risk. Use of a personal digital assistant or smart phone was associated with reported use of CHD risk assessment (adjusted OR 1.58; 95% CI 1.17-2.12).
  
  
  CONCLUSIONS
  Reported awareness of tools to calculate global CHD risk appears high, but the majority of physicians in this sample do not use CHD risk assessments in practice. A minority of physicians in this sample use global CHD risk to guide prescription decisions or to motivate patients. Educational interventions and system improvements to improve physicians' effective use of global CHD risk assessment should be developed and tested.
authors.affiliation: Department of Medicine, University of Colorado Denver School of Medicine, Denver, Colorado, USA.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Shillinglaw
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Viera
authors.forename: Teresa
authors.initials: T
authors.lastname: Edwards
authors.forename: Ross
authors.initials: R
authors.lastname: Simpson
authors.forename: Stacey L
authors.initials: SL
authors.lastname: Sheridan
mesh_terms: D002309:Cardiology / Q000706:statistics & numerical data; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D005194:Family Practice / Q000706:statistics & numerical data; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data; D007722:Health Knowledge, Attitudes, Practice; D006306:Health Surveys; D006801:Humans; D007388:Internal Medicine / Q000706:statistics & numerical data; D020407:Internet; D008297:Male; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011322:Primary Prevention / Q000379:methods*; D018570:Risk Assessment / Q000379:methods
chemical_list: D002317:Cardiovascular Agents